Recommendation ID

Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE website.

Any explanatory notes
(if applicable)

Research should ideally be in the form of pre-registered, adequately powered, randomised controlled trials. It should report details of patient selection, including the use of concurrent therapies, type, duration and frequency of stimulation, and the intended target in the brain. Outcomes should include improvement in symptoms, quality of life and duration of effect.

Source guidance details

Comes from guidance
Transcranial magnetic stimulation for obsessive-compulsive disorder
Date issued
August 2020

Other details

Is this a recommendation for the use of a technology only in the context of research? Yes  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 05/08/2020